Bhavnagri Veer (CIK 0001808980)

Latest company ownership

ALLO - Allogene Therapeutics, Inc.
Role: General Counsel
Shares held
556,049
Last filed at
Mar 16, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 14, 2023 Mar 16, 2023 Allogene Therapeutics, Inc. General Counsel Sell 42.5 -23,628 -4.08% ✗ $134K
Feb 13, 2023 Feb 14, 2023 Allogene Therapeutics, Inc. General Counsel Sell 51.3 -3,000 -0.52% ✓ $20.6K
Jan 17, 2023 Jan 18, 2023 Allogene Therapeutics, Inc. General Counsel Sell 51.3 -3,000 -0.51% ✓ $21.1K
Dec 15, 2022 Dec 19, 2022 Allogene Therapeutics, Inc. General Counsel Sell 51.3 -5,602 -0.95% ✓ $42.2K
Mar 15, 2022 Mar 17, 2022 Allogene Therapeutics, Inc. General Counsel Sell 42.5 -8,849 -2.09% ✗ $68K
Sep 15, 2021 Sep 17, 2021 Allogene Therapeutics, Inc. General Counsel Sell 45.0 -5,000 -1.17% ✓ $123.8K
Aug 16, 2021 Aug 17, 2021 Allogene Therapeutics, Inc. General Counsel Sell 45.0 -5,000 -1.17% ✓ $105K
Jul 15, 2021 Jul 16, 2021 Allogene Therapeutics, Inc. General Counsel Sell 45.0 -5,000 -1.17% ✓ $107.8K
Jun 15, 2021 Jun 16, 2021 Allogene Therapeutics, Inc. General Counsel Sell 45.0 -5,000 -1.17% ✓ $126.6K
May 18, 2021 May 20, 2021 Allogene Therapeutics, Inc. General Counsel Sell 45.0 -5,000 -1.17% ✓ $150K
May 17, 2021 May 17, 2021 Allogene Therapeutics, Inc. General Counsel Sell 45.0 -5,000 -1.17% ✓ $141.5K
Apr 15, 2021 Apr 16, 2021 Allogene Therapeutics, Inc. General Counsel Sell 38.8 -10,000 -2.32% ✓ $320.5K
Mar 15, 2021 Mar 17, 2021 Allogene Therapeutics, Inc. General Counsel Sell 35.0 -16,623 -4.00% ✓ $630.8K
Oct 6, 2020 Oct 8, 2020 Allogene Therapeutics, Inc. General Counsel Sell 38.8 -10,000 -2.75% ✓ $400K
Oct 1, 2020 Oct 2, 2020 Allogene Therapeutics, Inc. General Counsel Sell 30.0 -25,000 -6.60% ✓ $912.9K
Sep 1, 2020 Sep 3, 2020 Allogene Therapeutics, Inc. General Counsel Sell 30.0 -25,000 -6.60% ✓ $884K
Aug 3, 2020 Aug 5, 2020 Allogene Therapeutics, Inc. General Counsel Sell 23.8 -31,553 -8.19% ✓ $1.2M